Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Jul/Aug 2018 - Volume 22, Number 4
View All Articles in Issue

Page(s):  320

Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, metronidazole, anti-infective agent, antibiotic, antibacterial agent, antiprotozoal agent, antimicrobial agent

Related Categories: FORMULATIONS, INFECTIOUS DISEASE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Jul/Aug 2018
Pg. 320

Compounding for the Effects of Weapons of Mass Destruction
Sammarco Domenic A
Jan/Feb 2003
Pg. 10-15

View Sample
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98

Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T
, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Nov/Dec 2008
Pg. 558-564

Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 47

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents
Allen Loyd V Jr
May/Jun 2020
Pg. 206-212

Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Allen Loyd V Jr
May/Jun 2022
Pg. 238

Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
McElhiney Linda F
Jan/Feb 2021
Pg. 24-28

A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
Jul/Aug 2022
Pg. 270-274

Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets
Jarouche Marian
, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
Jan/Feb 2020
Pg. 77-82

Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2020
Pg. 60

A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
Nov/Dec 2022
Pg. 480-488

Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Allen Loyd V Jr
Jan/Feb 2020
Pg. 38-43

Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
Jul/Aug 2017
Pg. 301-308

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 1999
Pg. 309-310

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 412

Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 508

Return to Top